Beta Bionics, Inc. — Director's Dealing 2025

Nov 6, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beta Bionics, Inc. (BBNX)
CIK: 0001674632
Period of Report: 2025-10-31

Reporting Person: Lezack Adam (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-10-31	Common Stock	S	1368	$26.8474	Disposed	9879	Direct
2025-10-31	Common Stock	S	38	$27.70	Disposed	9841	Direct

Footnotes

F1: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025.

F2: The weighted average sale price for the transaction reported was $26.8474 and the range of prices were between $26.27 and $27.24. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.